Wednesday, October 14, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 19, 2026

Even auto giants know it: the electric car boom is out of charge

View original at uk.finance.yahoo.com
Even auto giants know it: the electric car boom is out of charge Why the West's electric car dream is running out of road Lead “I think the customer has spoken…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Competition in auto market in 2026 will be even more brutal and bloody

    80% confidence

  • Western brands will bring cheaper models using LFP battery technology

    80% confidence

  • EVs need cost parity with ICE cars and must offer more than just being clean

    80% confidence

  • Chinese have gotten EV pricing right by achieving parity or cheaper than ICE

    80% confidence

  • Big thing that drives car companies is what their competitors are doing

    80% confidence

  • Green energy transition is a scam

    80% confidence

  • Government sending mixed messages to industry and consumers

    80% confidence

  • Ground-up overhaul is needed to bring down cost of Western-made EVs

    80% confidence

  • The EV plans carmakers set out were too ambitious

    80% confidence

  • This is us going back to our roots

    80% confidence

  • Prices for consumers will fall and price parity will be met

    80% confidence

  • Government needs a reality check on EV mandates or risk carmakers pulling out of UK

    80% confidence

  • Global sales volumes haven't returned to pre-pandemic levels

    80% confidence

  • Universal Electric Vehicle platform is the most important product he has ever worked on

    80% confidence

  • F-150 Lightning was the truck of the future

    80% confidence

  • The customer has spoken regarding electric vehicles

    80% confidence

  • Weakening ZEV mandate would undermine investor confidence

    80% confidence

  • European consumer adoption of Chinese cars is much faster than Japanese or Korean cars

    80% confidence

  • Cracking EVs could deliver a modern Model T moment

    80% confidence

  • Not convinced China's ban on below-cost sales will stop price war

    80% confidence

  • Regulatory trajectories are steep and ahead of underlying demand

    80% confidence

  • Many drivers are still not comfortable making the shift to electric vehicles

    80% confidence

  • Most of the Western carmakers are now facing big issues

    80% confidence

  • Fundamental issue is cars are too expensive and compensated by subsidies which doesn't work

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Even auto giants know it: the electric car boom is out of charge — Source | Via News | Finance Via News